PG

Poonam Grover

Active Director Director DIN 10439826
DIN 10439826 First appointment Dec 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value •••• Premium profile

About Poonam Grover

Data last updated:

Poonam Grover is a Director at Grochem Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Grochem Pharmaceuticals Private Limited reported revenue of ₹5.5 Lakh (FY 2025).

DIN 10439826
Primary Designation Director
Industry Pharma
First Appointment 26 Dec 2023
Oldest Company Age 2 yrs
Largest company Grochem Pharmaceuticals Private Limited · ₹5.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Dec 20232023₹5.5 Lakh (FY 2025)Active

Board colleagues of Poonam Grover

NameDINCompanyDesignation
Komal Sood09766220Grochem Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Grochem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Poonam Grover

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Poonam Grover

Poonam Grover currently holds 1 directorship: Grochem Pharmaceuticals Private Limited (Director, since 26 Dec 2023, revenue ₹5.5 Lakh (FY 2025)).

Poonam Grover was first appointed on 26 Dec 2023 as Director at Grochem Pharmaceuticals Private Limited.

The current boards of Poonam Grover's companies include Komal Sood (Grochem Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available